Literature DB >> 22778812

Exploring the Backbone of Enkephalins To Adjust Their Pharmacological Profile for the δ-Opioid Receptor.

Arnaud Proteau-Gagné1, Véronique Bournival, Kristina Rochon, Yves L Dory, Louis Gendron.   

Abstract

The role of each of the four amide bonds in Leu(5)-enkephalin was investigated by systematically and sequentially replacing each with its corresponding trans-alkene. Six Leu(5)-enkephalin analogs based on six dipeptide surrogates and two Met(5)-enkephalin analogs were synthesized and thoroughly tested using a δ-opioid receptor internalization assay, an ERK1/2 activation assay, and a competition binding assay to evaluate their biological properties. We observed that an E-alkene can efficiently replace the first amide bond of Leu(5)- and Met(5)-enkephalin without significantly affecting biological activity. By contrast, the second amide bond was found to be highly sensitive to the same modification, suggesting that it is involved in biologically essential intra- or intermolecular interactions. Finally, we observed that the affinity and activity of analogs containing an E-alkene at either the third or fourth position were partially reduced, indicating that these amide bonds are less important for these intra- or intermolecular interactions. Overall, our study demonstrates that the systematic and sequential replacement of amide bonds by E-alkene represents an efficient way to explore peptide backbones.

Entities:  

Keywords:  E-alkene; Enkephalin; amide bond; dipeptide isostere; trans-olefin; δ-opioid receptor

Mesh:

Substances:

Year:  2010        PMID: 22778812      PMCID: PMC3368656          DOI: 10.1021/cn1000759

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  49 in total

1.  delta-Opioid receptors are more efficiently coupled to adenylyl cyclase than to L-type Ca(2+) channels in transfected rat pituitary cells.

Authors:  P L Prather; L Song; E T Piros; P Y Law; T G Hales
Journal:  J Pharmacol Exp Ther       Date:  2000-11       Impact factor: 4.030

2.  Structure of a GPCR ligand in its receptor-bound state: leukotriene B4 adopts a highly constrained conformation when associated to human BLT2.

Authors:  Laurent J Catoire; Marjorie Damian; Fabrice Giusti; Aimée Martin; Carine van Heijenoort; Jean-Luc Popot; Eric Guittet; Jean-Louis Banères
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

3.  Opioid receptor types selectively cointernalize with G protein-coupled receptor kinases 2 and 3.

Authors:  Rüdiger Schulz; Andrea Wehmeyer; Karin Schulz
Journal:  J Pharmacol Exp Ther       Date:  2002-02       Impact factor: 4.030

4.  Nitric oxide and cyclic GMP are involved in angiotensin II AT(2) receptor effects on neurite outgrowth in NG108-15 cells.

Authors:  Louis Gendron; Frédéric Côté; Marcel D Payet; Nicole Gallo-Payet
Journal:  Neuroendocrinology       Date:  2002-01       Impact factor: 4.914

5.  The role of delta-opioid receptor subtypes in neuropathic pain.

Authors:  J Mika; R Przewłocki; B Przewłocka
Journal:  Eur J Pharmacol       Date:  2001-03-09       Impact factor: 4.432

6.  Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.

Authors:  Daniel C Broom; Joshua F Nitsche; John E Pintar; Kenner C Rice; James H Woods; John R Traynor
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

7.  Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats.

Authors:  Daniel C Broom; Emily M Jutkiewicz; John E Folk; John R Traynor; Kenner C Rice; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2002-07-30       Impact factor: 4.530

8.  mu and delta-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization.

Authors:  H K Kramer; E J Simon
Journal:  Neuropharmacology       Date:  2000-07-24       Impact factor: 5.250

9.  Opioid receptor endocytosis and activation of MAP kinase pathway.

Authors:  N Trapaidze; I Gomes; S Cvejic; M Bansinath; L A Devi
Journal:  Brain Res Mol Brain Res       Date:  2000-03-29

10.  Diastereoselective synthesis of new psi[(E)-CH=CMe]- and psi[(Z)-CH=CMe]-type alkene dipeptide isosteres by organocopper reagents and application to conformationally restricted cyclic RGD peptidomimetics.

Authors:  Shinya Oishi; Takae Kamano; Ayumu Niida; Yoshihiko Odagaki; Nobuyuki Hamanaka; Mikio Yamamoto; Keiichi Ajito; Hirokazu Tamamura; Akira Otaka; Nobutaka Fujii
Journal:  J Org Chem       Date:  2002-08-23       Impact factor: 4.354

View more
  9 in total

1.  Preparation and evaluation at the delta opioid receptor of a series of linear leu-enkephalin analogues obtained by systematic replacement of the amides.

Authors:  Kristina Rochon; Arnaud Proteau-Gagné; Philippe Bourassa; Jean-François Nadon; Jérome Côté; Véronique Bournival; Fernand Gobeil; Brigitte Guérin; Yves L Dory; Louis Gendron
Journal:  ACS Chem Neurosci       Date:  2013-05-20       Impact factor: 4.418

Review 2.  Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.

Authors:  Shikha Kumari; Angelica V Carmona; Amit K Tiwari; Paul C Trippier
Journal:  J Med Chem       Date:  2020-08-04       Impact factor: 7.446

3.  Synthesis and Opioid Activity of Tyr1 -ψ[(Z)CF=CH]-Gly2 and Tyr1 -ψ[(S)/(R)-CF3 CH-NH]-Gly2 Leu-enkephalin Fluorinated Peptidomimetics.

Authors:  Somnath Narayan Karad; Mohan Pal; Rachel S Crowley; Thomas E Prisinzano; Ryan A Altman
Journal:  ChemMedChem       Date:  2017-04-05       Impact factor: 3.466

4.  Synthesis of Leu-Enkephalin Peptidomimetics Containing Trifluoromethylalkenes as Amide Isopolar Mimics.

Authors:  Venkateswararao Eeda; Manikandan Selvaraju; Ryan A Altman
Journal:  J Fluor Chem       Date:  2018-12-11       Impact factor: 2.050

5.  Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands.

Authors:  Krishna K Sharma; Robert J Cassell; Yazan J Meqbil; Hongyu Su; Arryn T Blaine; Benjamin R Cummins; Kendall L Mores; David K Johnson; Richard M van Rijn; Ryan A Altman
Journal:  RSC Med Chem       Date:  2021-08-16

6.  Systematic replacement of amides by 1,4-disubstituted[1,2,3]triazoles in Leu-enkephalin and the impact on the delta opioid receptor activity.

Authors:  Arnaud Proteau-Gagné; Kristina Rochon; Mélissa Roy; Pierre-Julien Albert; Brigitte Guérin; Louis Gendron; Yves L Dory
Journal:  Bioorg Med Chem Lett       Date:  2013-08-12       Impact factor: 2.823

7.  Tyr1-ψ[( Z)CF═CH]-Gly2 Fluorinated Peptidomimetic Improves Distribution and Metabolism Properties of Leu-Enkephalin.

Authors:  Ryan A Altman; Krishna K Sharma; Lian G Rajewski; Paul C Toren; Michael J Baltezor; Mohan Pal; Somnath N Karad
Journal:  ACS Chem Neurosci       Date:  2018-04-19       Impact factor: 4.418

8.  An Effective and Safe Enkephalin Analog for Antinociception.

Authors:  K K DurgaRao Viswanadham; Roland Böttger; Lukas Hohenwarter; Anne Nguyen; Elham Rouhollahi; Alexander Smith; Yi-Hsuan Tsai; Yuan-Yu Chang; Christopher Llynard Ortiz; Lee-Wei Yang; Liliana Jimenez; Siyuan Li; Chan Hur; Shyh-Dar Li
Journal:  Pharmaceutics       Date:  2021-06-22       Impact factor: 6.321

Review 9.  1,4-Disubstituted 1,2,3-Triazoles as Amide Bond Surrogates for the Stabilisation of Linear Peptides with Biological Activity.

Authors:  Lisa-Maria Rečnik; Wolfgang Kandioller; Thomas L Mindt
Journal:  Molecules       Date:  2020-08-06       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.